comparemela.com

Latest Breaking News On - Prnewswire protagonist therapeutics inc - Page 1 : comparemela.com

Protagonist Therapeutics to Participate in the JMP Securities Life Sciences Conference

/PRNewswire/ Protagonist Therapeutics, Inc. (Nasdaq: PTGX) ("Protagonist" or "the Company") today announced that Dinesh V. Patel, Ph.D., President and Chief.

New yorkUnited statesDineshv patelSecurities life sciences conferencePrnewswire protagonist therapeutics incProtagonist therapeutics incChief executive officerLife sciences conferenceNew york hiltonProtagonist therapeutics

Protagonist Therapeutics Announces Positive Topline Results for Phase 2b FRONTIER 1 Clinical Trial of Oral IL-23 Receptor Antagonist JNJ-2113 (PN-235) in Psoriasis

/PRNewswire/ Protagonist Therapeutics, Inc. (Nasdaq: PTGX) ("Protagonist" or "the Company"), today announced positive topline results from its collaboration.

Dineshv patelJanssen pharmaceutical companies of johnsonJanssen biotech incPrnewswire protagonist therapeutics incJanssen biotechJanssen pharmaceutical companiesPsoriasis areaSeverity indexChief executive officerProtagonist therapeutics

Protagonist Therapeutics to Present at the 41st Annual J P Morgan Healthcare Conference

/PRNewswire/ Protagonist Therapeutics, Inc. (Nasdaq: PTGX) ("Protagonist" or "the Company") today announced that Dinesh V. Patel, Ph.D., President and Chief.

United statesSan franciscoDineshv patelJanssen biotech incPrnewswire protagonist therapeutics incProtagonist therapeutics incChief executive officerHealthcare conferenceProtagonist therapeuticsJanssen biotech

Protagonist Therapeutics to Present at the 41st Annual J P Morgan Healthcare Conference

/PRNewswire/ Protagonist Therapeutics, Inc. (Nasdaq: PTGX) ("Protagonist" or "the Company") today announced that Dinesh V. Patel, Ph.D., President and Chief.

United statesSan franciscoDineshv patelJanssen biotech incPrnewswire protagonist therapeutics incProtagonist therapeutics incChief executive officerHealthcare conferenceProtagonist therapeuticsJanssen biotech

Protagonist Therapeutics to Participate in the JMP Securities Hematology and Oncology Summit

/PRNewswire/ Protagonist Therapeutics, Inc. (Nasdaq: PTGX) ("Protagonist" or "the Company") today announced that Dinesh V. Patel, Ph.D., President and Chief.

United statesDineshv patelJanssen biotech incPrnewswire protagonist therapeutics incProtagonist therapeutics incChief executive officerOncology summitProtagonist therapeuticsJanssen biotech

vimarsana © 2020. All Rights Reserved.